![Bahija Jallal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bahija Jallal
Chief Executive Officer at
IMMUNOCORE HOLDINGS PLC
Net worth: 137 M $ as of 2026-03-30
Profile
Bahija Jallal is currently Chief Executive Officer at Immunocore Holdings Plc and Chief Executive Officer & Director at Immunocore Ltd. since 2019.
Since 2018, the role of Independent Director at Elevance Health, Inc. is held.
Director positions are maintained at Umb Health Sciences Research Park Corp.
and Anthem, Inc. (DSG).
Trustee at The Johns Hopkins University since 2014.
Council Member at National Academies of Sciences.
Former roles include Independent Director at Guardant Health, Inc. from 2019 to 2022, Independent Director at Arrivent BioPharma, Inc. from 2022 to 2024, Vice President-Drug Assessment & Development at Chiron Corp.
from 2003 to 2006, President at MedImmune LLC from 2013 to 2019, Executive Vice President at AstraZeneca PLC from 2013 to 2019, President at Association for Women in Science from 2016 to 2018, Non-Executive Director at ADC Therapeutics SA, and Director at Viela Bio, Inc. Education includes a doctorate from Université Pierre et Marie Curie.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-17 | 4,505,482 ( 8.94% ) | 136 M $ | 2026-03-30 | |
| 2025-05-13 | 4,788 ( 0% ) | 1 M $ | 2026-03-30 |
Bahija Jallal active positions
| Companies | Position | Start |
|---|---|---|
| ELEVANCE HEALTH, INC. | Director/Board Member | 2018-01-31 |
| IMMUNOCORE HOLDINGS PLC | Chief Executive Officer | 2018-12-31 |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | 2013-12-31 |
Umb Health Sciences Research Park Corp.
 Umb Health Sciences Research Park Corp. The Umb Health Sciences Research Park Corp., also known as the BioPark, is a biomedical research park located on the academic medical center campus of the University of Maryland. It is a collaborative campus that houses life science companies and academic research centers focused on commercializing new drugs, diagnostics, and devices, as well as advancing biomedical research. The BioPark offers 250,000 square feet of lab and office space and is a hub for early-stage technology ventures. It is home to several companies, including Gliknik Inc., Vigilant Bioservices, Pharmaron, and Paragon Bioserve, which are dedicated to the discovery and development of novel biomolecules for autoimmune diseases and cancer, and providing secure storage and distribution of tissue and biologic materials for the biotechnology and transplant communities, respectively. Umb Health Sciences Research Park Corp. is based in Baltimore. | Director/Board Member | - |
National Academies of Sciences
 National Academies of Sciences Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy advisory services | Corporate Officer/Principal | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Chief Executive Officer | 2018-12-31 |
Anthem, Inc. (DSG) | Director/Board Member | - |
Former positions of Bahija Jallal
| Companies | Position | End |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Director/Board Member | 2024-02-29 |
| GUARDANT HEALTH, INC. | Director/Board Member | 2022-06-14 |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░ ░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Training of Bahija Jallal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology Develops madicines for the prevention and treatment of infectious diseases | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Guardant Health, Inc.
 Guardant Health, Inc. Medical/Nursing ServicesHealth Services Develops diagnostic technologies to improve cancer management | Health Services |
Elevance Health, Inc.
 Elevance Health, Inc. Managed Health CareHealth Services Provides health plans, clinical, behavioral, pharmacy and complex-care solutions | Health Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association for Women in Science
 Association for Women in Science Miscellaneous Commercial ServicesCommercial Services Promotes womens activities in all scientific fields, from mentoring to scholarships to job listings | Commercial Services |
National Academies of Sciences
National Academies of Sciences Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy advisory services | Commercial Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for severe inflammation and autoimmune diseases | Health Technology |
Umb Health Sciences Research Park Corp.
Umb Health Sciences Research Park Corp. The Umb Health Sciences Research Park Corp., also known as the BioPark, is a biomedical research park located on the academic medical center campus of the University of Maryland. It is a collaborative campus that houses life science companies and academic research centers focused on commercializing new drugs, diagnostics, and devices, as well as advancing biomedical research. The BioPark offers 250,000 square feet of lab and office space and is a hub for early-stage technology ventures. It is home to several companies, including Gliknik Inc., Vigilant Bioservices, Pharmaron, and Paragon Bioserve, which are dedicated to the discovery and development of novel biomolecules for autoimmune diseases and cancer, and providing secure storage and distribution of tissue and biologic materials for the biotechnology and transplant communities, respectively. Umb Health Sciences Research Park Corp. is based in Baltimore. | |
Anthem, Inc. (DSG) | |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
- Stock Market
- Insiders
- Bahija Jallal
